101 related articles for article (PubMed ID: 15969062)
1. [Construction and expression of anti-CD3/ anti-Pgp Diabody].
Gao YD; Xiong DS; Xu YF; Peng H; Shao XF; Yang CZ; Zhu ZP
Sheng Wu Gong Cheng Xue Bao; 2003 Jul; 19(4):444-9. PubMed ID: 15969062
[TBL] [Abstract][Full Text] [Related]
2. Efficient inhibition of multidrug-resistant human tumors with a recombinant bispecific anti-P-glycoprotein x anti-CD3 diabody.
Gao Y; Xiong D; Yang M; Liu H; Peng H; Shao X; Xu Y; Xu C; Fan D; Qin L; Yang C; Zhu Z
Leukemia; 2004 Mar; 18(3):513-20. PubMed ID: 14981526
[TBL] [Abstract][Full Text] [Related]
3. [Preparation and activity detection of monoclonal antibody against anti-CD3 ScFv].
Shao XF; Gao YD; Liu JN; Wang JH; Xu YF; Fan DM; Yang CZ; Xiong DS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Jun; 30(3):354-9. PubMed ID: 18686622
[TBL] [Abstract][Full Text] [Related]
4. [Specific targeting cytotoxicity to resistant leukemia cells mediated by anti-Pgp/anti-CD3 diabody].
Gao YD; Xiong DS; Yang M; Xu YF; Shao XF; Peng H; Fan DM; Yang CZ
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):342-4. PubMed ID: 16185477
[TBL] [Abstract][Full Text] [Related]
5. [Construction and expression of diabody [CD3 x Pgp] without Etag].
Liu JN; Gao YD; Wang JH; Shao XF; Fan DM; Ji Q; Xiong DS; Yang CZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):946-9. PubMed ID: 17908506
[TBL] [Abstract][Full Text] [Related]
6. Extracellular domain of 4-1BBL enhanced the antitumoral efficacy of peripheral blood lymphocytes mediated by anti-CD3 x anti-Pgp bispecific diabody against human multidrug-resistant leukemia.
Guo H; Jiang W; Liu W; Gao Y; Yang M; Zhou Y; Wang J; Qi J; Cheng X; Zhu Z; Yang C; Xiong D
Cell Immunol; 2008 Feb; 251(2):102-8. PubMed ID: 18482719
[TBL] [Abstract][Full Text] [Related]
7. A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells.
Bühler P; Wolf P; Gierschner D; Schaber I; Katzenwadel A; Schultze-Seemann W; Wetterauer U; Tacke M; Swamy M; Schamel WW; Elsässer-Beile U
Cancer Immunol Immunother; 2008 Jan; 57(1):43-52. PubMed ID: 17579857
[TBL] [Abstract][Full Text] [Related]
8. Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.
Fortmüller K; Alt K; Gierschner D; Wolf P; Baum V; Freudenberg N; Wetterauer U; Elsässer-Beile U; Bühler P
Prostate; 2011 May; 71(6):588-96. PubMed ID: 20945402
[TBL] [Abstract][Full Text] [Related]
9. [Construction and expression of disulphide stabilized anti-CD3/anti-Pgp diabody].
Su Y; Liu J; Gao Y; Qin L; Yang M; Wang J; Xu Y; Shao X; Ji Q; Xiong D; Yang C
Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1042-8. PubMed ID: 19835146
[TBL] [Abstract][Full Text] [Related]
10. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
[TBL] [Abstract][Full Text] [Related]
11. [An anti-P-gp/anti-CD3 bispecific antibody cytotoxic to human multidrug resistant KB cells].
Gao YD; Xiong DS; Yang M; Xu YF; Shao XF; Peng H; Fan DM; Yang CZ
Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):653-6. PubMed ID: 16438884
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive properties of anti-CD3 single-chain Fv and diabody.
Le Gall F; Reusch U; Moldenhauer G; Little M; Kipriyanov SM
J Immunol Methods; 2004 Feb; 285(1):111-27. PubMed ID: 14871540
[TBL] [Abstract][Full Text] [Related]
13. Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells.
Rodrigues ML; Shalaby MR; Werther W; Presta L; Carter P
Int J Cancer Suppl; 1992; 7():45-50. PubMed ID: 1428403
[TBL] [Abstract][Full Text] [Related]
14. [Parameters of specific antibody interaction with P-gp in T-cell leukemia Jurkat cells].
Bogush TA; Dudko EA; Bogush EA; Baryshnikov AIu
Antibiot Khimioter; 2009; 54(1-2):3-9. PubMed ID: 19499709
[TBL] [Abstract][Full Text] [Related]
15. Cure of Burkitt's lymphoma in severe combined immunodeficiency mice by T cells, tetravalent CD3 x CD19 tandem diabody, and CD28 costimulation.
Cochlovius B; Kipriyanov SM; Stassar MJ; Schuhmacher J; Benner A; Moldenhauer G; Little M
Cancer Res; 2000 Aug; 60(16):4336-41. PubMed ID: 10969772
[TBL] [Abstract][Full Text] [Related]
16. High level secretion of a humanized bispecific diabody from Escherichia coli.
Zhu Z; Zapata G; Shalaby R; Snedecor B; Chen H; Carter P
Biotechnology (N Y); 1996 Feb; 14(2):192-6. PubMed ID: 9636323
[TBL] [Abstract][Full Text] [Related]
17. Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas.
Helfrich W; Kroesen BJ; Roovers RC; Westers L; Molema G; Hoogenboom HR; de Leij L
Int J Cancer; 1998 Apr; 76(2):232-9. PubMed ID: 9537586
[TBL] [Abstract][Full Text] [Related]
18. [Expression and immunological activity of an anti-CD3×VEGFR2 bispecific single-chain antibody].
Dai LJ; Yan CW; Li SZ; Chen L; Li XY; Shan RH; Yu XW; Tang XB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Aug; 27(8):883-6. PubMed ID: 21806887
[TBL] [Abstract][Full Text] [Related]
19. Binding diversity of antibodies against external and internal epitopes of the multidrug resistance gene product P-glycoprotein.
Lehne G; De Angelis P; Clausen OP; Egeland T; Tsuruo T; Rugstad HE
Cytometry; 1995 Jul; 20(3):228-37. PubMed ID: 7587708
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.
Raghu G; Park SW; Roninson IB; Mechetner EB
Exp Hematol; 1996 Aug; 24(10):1258-64. PubMed ID: 8765502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
